IDEAYA Biosciences (IDYA) Enterprise Value (2019 - 2025)
Historic Enterprise Value for IDEAYA Biosciences (IDYA) over the last 7 years, with Q3 2025 value amounting to -$786.9 million.
- IDEAYA Biosciences' Enterprise Value rose 1447.07% to -$786.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$786.9 million, marking a year-over-year increase of 1447.07%. This contributed to the annual value of -$676.3 million for FY2024, which is 2879.47% down from last year.
- Latest data reveals that IDEAYA Biosciences reported Enterprise Value of -$786.9 million as of Q3 2025, which was up 1447.07% from -$669.7 million recorded in Q2 2025.
- In the past 5 years, IDEAYA Biosciences' Enterprise Value ranged from a high of -$246.8 million in Q4 2021 and a low of -$920.0 million during Q3 2024
- For the 5-year period, IDEAYA Biosciences' Enterprise Value averaged around -$491.2 million, with its median value being -$468.8 million (2023).
- Its Enterprise Value has fluctuated over the past 5 years, first crashed by 24408.23% in 2021, then soared by 1644.68% in 2022.
- IDEAYA Biosciences' Enterprise Value (Quarter) stood at -$246.8 million in 2021, then crashed by 47.84% to -$364.8 million in 2022, then tumbled by 43.93% to -$525.1 million in 2023, then dropped by 28.79% to -$676.3 million in 2024, then fell by 16.35% to -$786.9 million in 2025.
- Its Enterprise Value was -$786.9 million in Q3 2025, compared to -$669.7 million in Q2 2025 and -$692.5 million in Q1 2025.